REGINA, Saskatchewan, Feb. 05, 2024 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISV) (“ISC”, “we” or the “Company”) today announced its annual guidance and outlook for 2024.
- UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab) - March 26, 2025
- Proposals of the Board of Directors of Sampo plc and its Audit Committee to the Annual General Meeting - March 26, 2025
- Project update - March 26, 2025